Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials

Purpose Breast cancer (BC) is the most commonly diagnosed cancer and the second leading cause of cancer-related death among women. Given the availability of approved therapies and abundance of phase II and III clinical trials, historically few BC patients have been referred for consideration of part...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research and treatment 2018-02, Vol.168 (1), p.35-41
Hauptverfasser:	Lynce, Filipa, Blackburn, Matthew J., Cai, Ling, Wang, Heping, Rubinstein, Larry, Harris, Pamela, Isaacs, Claudine, Pohlmann, Paula R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic agents Antineoplastic Agents - adverse effects Breast cancer Breast Neoplasms - drug therapy Cancer diagnosis Cancer patients Cancer research Cancer therapies Cancer treatment Clinical Trial Clinical trials Clinical Trials, Phase I as Topic - economics Clinical Trials, Phase I as Topic - statistics & numerical data Diagnosis Drug-Related Side Effects and Adverse Reactions - epidemiology Drug-Related Side Effects and Adverse Reactions - etiology Enrollments Female Humans Medical schools Medicine Medicine & Public Health Middle Aged National Cancer Institute (U.S.) - economics Oncology Patient outcomes Patient Selection Product development Response Evaluation Criteria in Solid Tumors Retrospective Studies Time Factors Toxicity United States Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!